Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Is this poster new (since it is below "Upcoming Ev

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154867
(Total Views: 364)
Posted On: 06/15/2019 6:59:08 AM
Avatar
Posted By: lorbas
Re: trding #4027
Is this poster new (since it is below "Upcoming Events"?): "Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer metastasis and enhances cell death induced by DNA damaging chemotherapy"
https://s3.amazonaws.com/content.stockpr.com/...%20(1).pdf


Regarding the videos: I think only those with little credibility and a clear negative agenda like Amatuer complain about the videos per se. Clearly, it's a good idea to keep in touch with the shareholder base.

BUT: it would have been good to use these videos to actually explain e.g. in more detail the unexpected delay in TNBC, something which is on the mind of most of us and the second most important objective of the company besides Combo BLA submission. As far as I remember, EvilRabbit was promised a week ago that this was to be addressed in the next video.

More important, however, would be to spread the word about CYDY paradigm-shifting science and medicine by managing their social media accounts properly and so on. This could even be a part-time job for e.g. a student and would cost the company very little and would have an immediate effect. Not only spreading the word on social media, but contact specific organisations, foundations and so on.

Moreover, in my eyes, a couple of things don't add up regarding the prognostic test: last year, before the merger, Pestell was said to be in advanced negotiations with interested parties. Now, 8 months later, CYDY has yet to receive a term-sheet. In addition, why didn't they bring in negotiation and business experts much sooner?

Last but not least: can't the board members with their influence and contacts do more for CYDY on the financial side? What about Klump?


(0)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us